Multimodal cell death drives the immunopathogenesis of RSV infection

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Respiratory syncytial virus (RSV) causes severe respiratory infections, particularly in vulnerable populations.
• Current therapies for RSV are limited due to an incomplete understanding of disease mechanisms.
• RSV infection involves complex interactions between host cells and the immune system.

Purpose of the Study:

• To review recent advancements in understanding the multimodal cell death (MMCD) network in RSV infection.
• To elucidate the role of MMCD in shaping RSV immunopathogenesis and disease outcomes.
• To explore potential therapeutic strategies targeting the MMCD network for RSV treatment.

Main Methods:

• Review of existing scientific literature and research on regulated cell death (RCD) pathways in RSV.
• Analysis of molecular mediators and signaling hubs (e.g., caspase-8, RIPK3, NLRP3) coordinating RCD.
• Integration of findings to establish a framework linking cell death, inflammation, and immune dysfunction.

Main Results:

• RSV activates multiple RCD programs (apoptosis, necroptosis, pyroptosis, ferroptosis, autophagy-associated cell death).
• These RCD programs interact via shared mediators, forming an integrated MMCD network.
• The MMCD network balances viral clearance with immunopathological injury, involving key mediators like caspase-8, RIPK3, and NLRP3.

Conclusions:

• The MMCD network is a critical determinant of RSV immunopathogenesis and disease severity.
• Understanding the MMCD network offers a unified framework for linking cell death to immune dysfunction in RSV.
• Targeting the MMCD network presents a promising avenue for developing novel, precision therapies for RSV.